# CVS Health

Type: Company

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/cvs-health
Canonical HTML page: https://gethealthbrief.com/entity/cvs-health

## Timeline

- **2024-06**: Supreme Court Ruling — SCOTUS maintains access to mifepristone by dismissing a challenge to FDA's rules on procedural grounds.
- **2023-01**: Pharmacy Certification — FDA updates REMS to allow retail pharmacies to dispense mifepristone upon certification.
- **2021-12**: Mail-Order Authorization — FDA permanently removes the requirement for in-person dispensing, allowing for telehealth and mail delivery.
- **2016-03**: Protocol Expansion — FDA extends usage window to 10 weeks and reduces required office visits from three to one.
- **2000-09**: Initial FDA Approval — FDA approves mifepristone for medical termination of pregnancy through seven weeks.

## Recent coverage (2 stories)

### Over 500 Tylenol suits revived: Prenatal care guidelines under microscope
2026-07-25 19:57:02 · Sentiment: Negative · Impact: 7/10 · Sources: 2

The legal reinstatement of Tylenol-autism lawsuits pressures healthcare providers to reconcile conflicting evidence on acetaminophen safety in pregnancy, potentially altering clinical guidance, patient counseling, and EHR decision support.
Full story: https://gethealthbrief.com/story/tylenol-autism-lawsuits-revived-health

### Medication Abortion Becomes Primary Method Amid Escalating Regulatory Warfare
2026-03-24 07:42:54 · Sentiment: Neutral · Impact: 7/10 · Sources: 2

Medication abortion now accounts for the majority of pregnancy terminations in the United States, driven by the expansion of telehealth and mail-order pharmacy access. This shift has sparked a sophisticated regulatory counter-offensive from opponents targeting FDA-approved protocols and cross-state digital health providers.
Full story: https://gethealthbrief.com/story/medication-abortion-regulation-trends-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.